|Opioid-prescribing guidelines for common surgical procedures: an expert panel consensus|
HN Overton, MN Hanna, WE Bruhn, S Hutfless, MC Bicket, MA Makary, ...
Journal of the American College of Surgeons 227 (4), 411-418, 2018
|Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection|
G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ...
Annals of surgery 270 (2), 340, 2019
|Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma|
VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ...
Annals of surgery, 2019
|Is a pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer?|
J He, AB Blair, VP Groot, AA Javed, RA Burkhart, G Gemenetzis, ...
Annals of surgery 268 (1), 1, 2018
|A roadmap for aspiring surgeon-scientists in today’s healthcare environment|
AM Goldstein, AB Blair, SG Keswani, A Gosain, M Morowitz, J Kuo, ...
Annals of surgery 269 (1), 66, 2019
|Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma|
VP Groot, G Gemenetzis, AB Blair, D Ding, AA Javed, RA Burkhart, J Yu, ...
Annals of surgical oncology 25 (8), 2475-2483, 2018
|BRCA1/BRCA2 germline mutation carriers and sporadic pancreatic ductal adenocarcinoma|
AB Blair, VP Groot, G Gemenetzis, J Wei, JL Cameron, MJ Weiss, ...
Journal of the American College of Surgeons 226 (4), 630-637. e1, 2018
|A unifying theory of tonsillitis, intratonsillar abscess and peritonsillar abscess|
AB Blair, R Booth, R Baugh
American journal of otolaryngology 36 (4), 517-520, 2015
|IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma|
AB Blair, J Kleponis, DL Thomas, ST Muth, AG Murphy, V Kim, L Zheng
The Journal of clinical investigation 129 (4), 1742-1755, 2019
|Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer|
MT Saung, S Muth, D Ding, DL Thomas, AB Blair, T Tsujikawa, ...
Journal for immunotherapy of cancer 6 (1), 1-11, 2018
|Outcome of patients with borderline resectable pancreatic cancer in the contemporary era of neoadjuvant chemotherapy|
AA Javed, MJ Wright, A Siddique, AB Blair, D Ding, RA Burkhart, ...
Journal of Gastrointestinal Surgery 23 (1), 112-121, 2019
|Patient-and caregiver-reported assessment tools for palliative care: summary of the 2017 agency for healthcare research and quality technical brief|
RA Aslakson, SM Dy, RF Wilson, J Waldfogel, A Zhang, SR Isenberg, ...
Journal of pain and symptom management 54 (6), 961-972. e16, 2017
|Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies|
VM Kim, AB Blair, P Lauer, K Foley, X Che, K Soares, T Xia, ST Muth, ...
Journal for immunotherapy of cancer 7 (1), 1-13, 2019
|Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer|
VP Groot, AB Blair, G Gemenetzis, D Ding, RA Burkhart, J Yu, ...
European Journal of Surgical Oncology 45 (9), 1674-1683, 2019
|Dissecting the stromal signaling and regulation of myeloid cells and memory effector T cells in pancreatic cancer|
AB Blair, VM Kim, ST Muth, MT Saung, N Lokker, B Blouw, TD Armstrong, ...
Clinical Cancer Research 25 (17), 5351-5363, 2019
|Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation …|
AB Blair, LM Rosati, N Rezaee, G Gemenetzis, L Zheng, RH Hruban, ...
Surgery 163 (5), 1090-1096, 2018
|Postoperative urinary retention after inguinal hernia repair: a single institution experience|
AB Blair, A Dwarakanath, A Mehta, H Liang, X Hui, C Wyman, ...
Hernia 21 (6), 895-900, 2017
|Management of locally advanced pancreatic cancer: results of an international survey of current practice|
BN Reames, AB Blair, RW Krell, VP Groot, G Gemenetzis, JC Padussis, ...
Annals of surgery, 2021
|Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future|
AB Blair, A Murphy
Current problems in cancer 42 (1), 49-58, 2018
|Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer|
B Shrestha, Y Sun, F Faisal, V Kim, K Soares, A Blair, JM Herman, ...
Cancer medicine 6 (7), 1552-1562, 2017